Gene · 2249
Papers3,660
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,660
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Insights into Anthocyanin Synthesis in the Calyx of Roselle Using Integrated Transcriptomic and Metabolomic Analyses. | Int J Mol Sci | 2022 | 36430383 | PubTator, text mining | PubMed |
| Cell-Free DNA Sequencing Reveals Gene Variants in DNA Damage Repair Genes Associated with Prognosis of Prostate Cancer Patients. | Cells | 2022 | 36429046 | PubTator, text mining | PubMed |
| Combined Lorlatinib, Dabrafenib, and Trametinib Treatment for ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer with a Lorlatinib-Induced BRAF V600E Mutation: A Case Report. | Cancer Manag Res | 2022 | 36411743 | PubTator, text mining | PubMed |
| Effectiveness of short-term isothermic-heat acclimation (4 days) on physical performance in moderately trained males. | PLoS One | 2022 | 36395344 | PubTator, text mining | PubMed |
| Predicting Response to Radiotherapy in Breast Cancer-Induced Bone Pain: Relationship Between Pain and Serum Cytokine Expression Levels After Radiotherapy. | J Pain Res | 2022 | 36394055 | PubTator, text mining | PubMed |
| Effects of Hst3p inhibition in Candida albicans: a genome-wide H3K56 acetylation analysis. | Front Cell Infect Microbiol | 2022 | 36389164 | PubTator, text mining | PubMed |
| Bioinformatics analysis and validation of the critical genes associated with adamantinomatous craniopharyngioma. | Front Oncol | 2022 | 36387067 | PubTator, text mining | PubMed |
| Tetrabromobisphenol A effects on differentiating mouse embryonic stem cells reveals unexpected impact on immune system. | Front Genet | 2022 | 36386828 | PubTator, text mining | PubMed |
| Paracrine interactions through FGFR1 and FGFR2 receptors regulate the development of preimplantation mouse chimaeric embryo. | Open Biol | 2022 | 36382369 | PubTator, text mining | PubMed |
| Laminin111-based defined culture promoting self-renewing human pluripotent stem cells with properties of the early post-implantation epiblast. | Stem Cell Reports | 2022 | 36368331 | PubTator, text mining | PubMed |
| Loss of mismatch repair promotes a direct selective advantage in human stem cells. | Stem Cell Reports | 2022 | 36368329 | PubTator, text mining | PubMed |
| Optimized Transcriptional Signature for Evaluation of MEK/ERK Pathway Baseline Activity and Long-Term Modulations in Ovarian Cancer. | Int J Mol Sci | 2022 | 36362153 | PubTator, text mining | PubMed |
| Siglec-6 Signaling Uses Src Kinase Tyrosine Phosphorylation and SHP-2 Recruitment. | Cells | 2022 | 36359823 | PubTator, text mining | PubMed |
| Genomic and Immune Approach in Platinum Refractory HPV-Negative Head and Neck Squamous Cell Carcinoma Patients Treated with Immunotherapy: A Novel Combined Profile. | Biomedicines | 2022 | 36359251 | PubTator, text mining | PubMed |
| Hesperetin, a Promising Dietary Supplement for Preventing the Development of Calcific Aortic Valve Disease. | Antioxidants (Basel) | 2022 | 36358465 | PubTator, text mining | PubMed |
| Molecular Characterization of Secreted Factors and Extracellular Vesicles-Embedded miRNAs from Bone Marrow-Derived Mesenchymal Stromal Cells in Presence of Synovial Fluid from Osteoarthritis Patients. | Biology (Basel) | 2022 | 36358333 | PubTator, text mining | PubMed |
| Heat acclimation does not negatively affect salivary immunoglobulin-A and self-reported illness symptoms and wellness in recreational athletes. | Temperature (Austin) | 2022 | 36339091 | PubTator, text mining | PubMed |
| Onosma L. as a source of anticancer agents: phytochemistry to mechanistic insight. | Explor Target Antitumor Ther | 2022 | 36338520 | PubTator, text mining | PubMed |
| Systems biology and OMIC data integration to understand gastrointestinal cancers. | World J Clin Oncol | 2022 | 36337313 | PubTator, text mining | PubMed |
| Subcellular location of source proteins improves prediction of neoantigens for immunotherapy. | EMBO J | 2022 | 36314681 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2249/papers?page=24